US EditionPublished • loading... • Updated
CSL plans $1.5b US manufacturing push
Summary by Manufacturers' Monthly
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CSL plans $1.5b US manufacturing push
Image: Grispb/stock.adobe.comGlobal biopharmaceutical company CSL has announced plans to invest approximately US$1.5 billion in its United States operations over the next five years, expanding its manufacturing capability for plasma-derived therapies (PDTs) and generating hundreds of skilled American jobs. The plan builds on more than US$3 billion the company has already invested in the US since 2018, growth that has created more than 6,500 new …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
